A Gaucher Disease Gene Therapy Trial With FLT201

Recruiting

Phase 3

FLT201A Gaucher Disease Gene Therapy Trial With FLT201

Sponsor:

Spur Therapeutics

Code:

NCT07223944

Conditions

Gaucher Disease Type 1

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

FLT201

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-28. This information was provided to ClinicalTrials.gov by Spur Therapeutics on 2026-04-21.